SCHEDULE 13D/AAccepted Feb 17, 8:14 PM ET
Kalaris Therapeutics, Inc. SCHEDULE 13D/A
Accepted (ET)
8:14 PM
Feb 17, 2026
Filed
Feb 17, 2026
Documents
1
Size
14.6 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.